跳至主要内容
临床试验/JPRN-UMIN000026394
JPRN-UMIN000026394已完成4 期

Comparison in the efficacy of the two add on therapies with an anticholinergic agent versus a beta3-adrenoceptor agonist for patients with benign prostatic enlargement complicated by overactive bladder after alpha1-blocker administration, A randomized, prospective trial using a urodynamic study - Comparison in the efficacy of the two add on therapies with an anticholinergic agent versus a beta3-adrenoceptor agonist for BPH/OAB

agoya University Graduate School of Medicine0 个研究点目标入组 100 人开始时间: 2017年3月10日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50years-old 至 90years-old(—)
性别
Male

入选标准

  • 未提供

排除标准

  • Patients were excluded if they received oral treatment with propafenone hydrochloride, flecainide acetate, anticholinergic agents, antidepressants, anti-anxiety agents, or sex hormonal agents; had neurogenic bladder dysfunction, bladder calculi, or active urinary tract infection; and had severe cardiac disease, renal dysfunction (serum creatinine level more than 2 mg/dL), and hepatic dysfunction (aspartate and alanine aminotransferase concentrations more than twice the normal values).

研究者

发起方
agoya University Graduate School of Medicine

相似试验